consoliDateD stateMents of changes in equity Astellas Pharma Inc. and Subsidiaries  For the years ended 31 March 2013 and 2014 Astellas Pharma Inc.  _ Annual Report 2014 106 (Millions of U.S. dollars) Equity attributable to owners of the parent Total equity Share  capital Capital  surplus Treasury  shares Retained  earnings Other components of equity Total Note Subscription  rights to  shares Foreign  currency  translation  adjustments Fair value  movements  on available- for-sale  financial  assets Re-  measurements  of defined  benefit plans Total As of 31 March 2013 $1,000 $1,717 $(702) $8,500 $19 $ 657 $214 $ — $ 889 $11,404 $11,404 Comprehensive income Profit for the year — — — 882 — — — — — 882 882 Other comprehensive income — — — — — 777 64 45 886 886 886 Total comprehensive income — — — 882 — 777 64 45 886 1,768 1,768 Transactions with owners of the parent Acquisition of treasury shares 25 — — (292) — — — — — — (292) (292) Disposals of treasury shares 25 — — 4 (1) (2) — — — (2) 1 1 Cancellation of treasury shares 25 — — 460 (460) — — — — — — — Dividends 26 — — — (569) — — — — — (569) (569) Share-based payments 27 — — — — 4 — — — 4 4 4 Transfers — — — 45 — — — (45) (45) — — Total transactions with owners of the parent — — 172 (986) 2 — — (45) (43) (857) (857) As of 31 March 2014 $1,000 $1,717 $(529) $8,396 $20 $1,434 $278 $ — $1,732 $12,315 $12,315 (Millions of yen) Equity attributable to owners of the parent Total equity Share  capital Capital  surplus Treasury  shares Retained  earnings Other components of equity Total Note Subscription  rights to  shares Foreign  currency  translation  adjustments Fair value  movements  on available- for-sale  financial  assets Re-  measurements  of defined  benefit plans Total As of 1 April 2012 ¥103,001 ¥176,822 ¥(23,132) ¥ 848,135 ¥1,605 ¥ — ¥18,727 ¥ — ¥ 20,332 ¥1,125,157 ¥1,125,157 Comprehensive income Profit for the year — — — 92,464 — — — — — 92,464 92,464 Other comprehensive income — — — — — 67,659 3,273 (5,049) 65,883 65,883 65,883 Total comprehensive income — — — 92,464 — 67,659 3,273 (5,049) 65,883 158,347 158,347 Transactions with owners of the parent Acquisition of treasury shares 25 — — (49,392) — — — — — — (49,392) (49,392) Disposals of treasury shares 25 — — 239 (27) (42) — — — (42) 170 170 Dividends 26 — — — (60,051) — — — — — (60,051) (60,051) Share-based payments 27 — — — — 374 — — — 374 374 374 Transfers — — — (5,049) — — — 5,049 5,049 — — Total transactions with owners of the parent — — (49,153) (65,127) 332 — — 5,049 5,381 (108,899) (108,899) As of 31 March 2013 103,001 176,822 (72,285) 875,473 1,937 67,659 22,000 — 91,596 1,174,606 1,174,606 Comprehensive income Profit for the year — — — 90,874 — — — — — 90,874 90,874 Other comprehensive income — — — — — 80,001 6,588 4,648 91,238 91,238 91,238 Total comprehensive income — — — 90,874 — 80,001 6,588 4,648 91,238 182,112 182,112 Transactions with owners of the parent Acquisition of treasury shares 25 — — (30,075) — — — — — — (30,075) (30,075) Disposals of treasury shares 25 — — 463 (147) (192) — — — (192) 124 124 Cancellation of treasury shares 25 — — 47,362 (47,362) — — — — — — — Dividends 26 — — — (58,656) — — — — — (58,656) (58,656) Share-based payments 27 — — — — 365 — — — 365 365 365 Transfers — — — 4,648 — — — (4,648) (4,648) — — Total transactions with owners of the parent — — 17,750 (101,517) 173 — — (4,648) (4,475) (88,242) (88,242) As of 31 March 2014 ¥103,001 ¥176,822 ¥(54,535) ¥ 864,830 ¥2,110 ¥147,660 ¥28,588 ¥ — ¥178,359 ¥1,268,476 ¥1,268,476